All people encounter, inhale, and ingest fungi on a daily basis. Although only several hundred of the estimated five million species of fungi worldwide cause disease in humans, advances in medical technologies and the global AIDS pandemic have dramatically increased our susceptibility to fungal disease.
Tobias M. Hohl, MD, PhD
Chief, Infectious Diseases Service
Associate Professor
Research Focus
Physician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.Education
- MD, Weill Medical College of Cornell University
- PhD, Weill Graduate School of Medical Sciences of Cornell University
Lab Members
Lena Heung
Assistant Attending L1
Shinji Kasahara
Research Associate
Neta Shlezinger
Research Scholar
Benjamin Y. Tischler
Graduate Student
Nick Tosini
Research Technician
Bing Zhai
Research Fellow
Publications
- Shlezinger N, Irmer I, Dhingra S, Beattie SR, Cramer RA, Braus GH, Sharon A, and Hohl TM. Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death. Science. 357:1037-1041.
- Kasahara S, Jhingran A, Dhingra S, Salem A, Cramer R, Hohl TM. Role of granulocyte-macrophage colony-stimulating factor signaling in regulating neutrophil antifungal activity and the oxidative burst during respiratory fungal challenge. J Infect Dis. 213:1289-1298, 2016.
Selected Achievements
- Investigator in the Pathogenesis of Infectious Diseases, Burrroughs Wellcome Fund (2014)
- Fellow, Infectious Diseases Society of America (2012)
- Young Investigator Award, American Society of Microbiology (2009)
- Member, American Society of Clinical Investigation (2016)
